-
Mashup Score: 1Adding Perioperative Nivolumab to Neoadjuvant Chemotherapy in Resectable NSCLC: CheckMate 77T - 5 hour(s) ago
Interim analysis in the phase III CheckMate 77T trial has shown that the addition of perioperative nivolumab to neoadjuvant chemotherapy improved event-free survival in patients with resectable NSCLC.
Source: ascopost.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Nivolumab/Ipilimumab Boost in Metastatic Urothelial Carcinoma - 6 hour(s) ago
A recent report described outcomes with the use of nivolumab plus ipilimumab as an immunotherapeutic boost in metastatic urothelial carcinoma.
Source: ascopost.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Pertuzumab Plus Trastuzumab for Advanced Biliary Tract Cancer With HER2/3 Alterations - 8 hour(s) ago
A cohort of the phase II TAPUR basket study investigated the efficacy of the combination of pertuzumab and trastuzumab in patients with advanced biliary tract cancer and HER2/3 amplification, overexpr…
Source: ascopost.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 4NCCN Clinical Practice Guidelines in Oncology: 2024 Updates - 9 hour(s) ago
The National Comprehensive Cancer Network® published its first set of Clinical Practice Guidelines in Oncology (NCCN Guidelines®) in 1996, covering eight tumor types. Currently, guidelines are availab…
Source: ascopost.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0End-of-Life Systemic Therapy May Not Improve Survival in Patients With Advanced Solid Tumors - 10 hour(s) ago
What is the overall survival benefit of systemic therapy in patients with advanced solid tumors? A recent cohort study investigated.
Source: ascopost.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 3Bariatric Surgery May Help Reduce the Risk of Breast Cancer in Female Patients With Obesity, Hyperinsulinemia - 11 hour(s) ago
Investigators have explored whether bariatric surgery may be associated with a reduced risk of breast cancer in female patients with obesity and/or hyperinsulinemia at the time of surgery.
Source: ascopost.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 3
Undetectable measurable residual disease (MRD) status at 1 year after autologous hematopoietic cell transplantation and lenalidomide maintenance therapy was associated with improved progression-free a…
Source: ascopost.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 4
In an update of a Norwegian trial, researchers found that long term, salvage reirradiation for locally recurrent prostate cancer was feasible and associated with good outcomes.
Source: ascopost.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 8Definitive Concurrent Chemoradiotherapy for Unresectable Locally Advanced Esophageal Cancer: Comparison of Agents - 3 day(s) ago
In a Chinese phase III trial, researchers found that neither capecitabine nor XELOX (capecitabine, oxaliplatin) improved 2-year overall survival vs cisplatin/fluorouracil as part of definitive concurr…
Source: ascopost.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 3Childhood Adiposity and Risk for Breast Cancer - 3 day(s) ago
Investigators examined the impact of a higher adiposity in childhood on tissue formation and the risk of breast cancer.
Source: ascopost.comCategories: General Medicine News, Onc News and JournalsTweet
Adding Perioperative Nivolumab to Neoadjuvant Chemotherapy in Resectable NSCLC: CheckMate 77T https://t.co/ntJWYqzbTN #immunotherapy #oncology #LCSM #lungcancer